Our Cancer in Primary Care Research Group conducts research covering the role of primary care across the cancer continuum. This includes studies on cancer screening, cancer diagnosis and survivorship care. We are interested in the application of risk stratification and risk assessment tools to support more tailored and specific care across the cancer continuum. This includes, for example, our work in colorectal cancer screening and the implementation of fast track pathways for suspected cancer using risk assessment tools in general practice. Recently funded work includes trials of polygenic risk scores to tailor cancer screening and development of decision support tools to flag patients with abnormal blood test results, which places them at increased risk of a cancer diagnosis.
Melbourne's CanTest projects
The Melbourne CanTest research focuses on innovative technologies that can be applied for tailored cancer screening and early diagnosis. This includes genomic tests to predict future risk of bowel and other cancers, electronic risk assessment and decision support tools and mobile health applications. We are also involved in collaborative systematic reviews within the CanTest group of biomarkers for gastro-intestinal cancers.